in vivo News and Research

RSS

New study classifies CSU skin eruptions into five categories using mathematical modeling

Chronic spontaneous urticaria (CSU), a skin condition marked by sudden eruptions.

6 Dec 2023

Revolutionary self-folding nanoscale MRI agent sharpens cancer imaging

Study introduces a novel self-folding nanoscale contrast agent for MRI, enhancing tumor visualization with lower gadolinium loads and reduced risk of adverse effects.

5 Dec 2023

Osteopontin-c: A key player in mitochondrial biogenesis and cancer metastasis

A new research paper was published in Oncotarget's Volume 14 on December 1, 2023, entitled, "Osteopontin induces mitochondrial biogenesis in deadherent cancer cells."

5 Dec 2023

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH).

From CN-Bio 4 Dec 2023

Painless ultrasound vaccine delivery on the horizon

An estimated quarter of adults and two-thirds of children have strong fears around needles, according to the U.S. Centers for Disease Control and Prevention.

3 Dec 2023

Nanotechnology could enhance traditional Chinese medicine delivery, promising improved clinical outcomes

This review in the Journal of Nanobiotechnology explores how nanotechnology enhances the delivery of traditional Chinese medicines (TCMs), overcoming challenges like poor solubility and limited bioavailability. Nanocarriers like liposomes and nanoparticles improve TCM delivery, offering greater therapeutic effectiveness and reduced side effects, but face challenges in biocompatibility and stability for clinical use.

30 Nov 2023

The effects of vitamin K on bone health

Existing scientific data on the effects of vitamin K (VK) on bone health and elucidated the underlying mechanisms.

30 Nov 2023

Drug-eluting hydrogel has enhanced capabilities for treating hepatocellular carcinoma

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with enhanced capabilities for treating hepatocellular carcinoma (HCC), a deadly form of liver cancer.

29 Nov 2023

Study finds diet-derived trans-vaccenic acid boosts anti-tumor immunity

Dietary components that impact anti-tumor immunity.

28 Nov 2023

Pomegranate's power: Studies show promise in cardiovascular and diabetic health

Researchers reviewed existing data on the bio-modulatory effects of pomegranate (Punica granatum l., PG) polyphenols on metabolic disorders.

24 Nov 2023

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

CN Bio has received the ‘Most Impactful Industry Collaboration of the Year’ at the 2023 OBN Awards.

From CN-Bio 23 Nov 2023

Exploring the impact of soy isoflavones in prostate cancer therapy

The cellular mechanisms of soy isoflavones, genistein, daidzein, and equol.

23 Nov 2023

MRI scans reveal distinct brain changes in people with long COVID

People with long COVID exhibit patterns of changes in the brain that are different from fully recovered COVID-19 patients, according to research being presented next week at the annual meeting of the Radiological Society of North America.

22 Nov 2023

Combined application of therapeutic viruses and nanomaterials to revolutionize cancer therapy

Using oncolytic viruses (OVs) in combination with nanomaterials as a novel approach to cancer treatment.

22 Nov 2023

Scientists create living phlegm replica to study cystic fibrosis infections

Scientists have engineered a living material resembling human phlegm, which will help them to better understand how a certain kind of infection develops on the lungs of patients with cystic fibrosis.

21 Nov 2023

Scientists uncover key to enhancing cancer-killing T cells

T cells are the key immune system component involved in killing cancer. Tumors produce signals that turn off these T cells, partially by forcing them to progressively differentiate (mature) into a hypofunctional state known as exhaustion.

21 Nov 2023

Pitt researcher receives $1.95 million grant to study cell communication

Day by day, we communicate with our office colleagues to accomplish tasks that are necessary to function.

21 Nov 2023

Breakthrough in HIV treatment: NMN shows promise in reducing CD4+ T cell activation

The impact of nicotinamide mononucleotide (NMN) on Clusters of differentiation 4+ (CD4+ ) Thymus cells (T cells) viz.

21 Nov 2023

Study highlights glycolysis as a potential therapeutic target to combat Mycobacterium tuberculosis

It has been uncertain how Mycobacterium tuberculosis deflects the immune response in humans, though evidence has pointed to host immunometabolism -; the intrinsic link between metabolism in immune cells and their immune function.

20 Nov 2023

First-of-its-kind study reveals a new culprit in the formation of brain hemorrhages

A first-of-its-kind study led by the University of California, Irvine has revealed a new culprit in the formation of brain hemorrhages that does not involve injury to the blood vessels, as previously believed.

20 Nov 2023

in vivo News and Research

New study classifies CSU skin eruptions into five categories using mathematical modeling

Revolutionary self-folding nanoscale MRI agent sharpens cancer imaging

Osteopontin-c: A key player in mitochondrial biogenesis and cancer metastasis

CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

Painless ultrasound vaccine delivery on the horizon

Nanotechnology could enhance traditional Chinese medicine delivery, promising improved clinical outcomes

The effects of vitamin K on bone health

Drug-eluting hydrogel has enhanced capabilities for treating hepatocellular carcinoma

Study finds diet-derived trans-vaccenic acid boosts anti-tumor immunity

Pomegranate's power: Studies show promise in cardiovascular and diabetic health

CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA

Exploring the impact of soy isoflavones in prostate cancer therapy

MRI scans reveal distinct brain changes in people with long COVID

Combined application of therapeutic viruses and nanomaterials to revolutionize cancer therapy

Scientists create living phlegm replica to study cystic fibrosis infections

Scientists uncover key to enhancing cancer-killing T cells

Pitt researcher receives $1.95 million grant to study cell communication

Breakthrough in HIV treatment: NMN shows promise in reducing CD4+ T cell activation

Study highlights glycolysis as a potential therapeutic target to combat Mycobacterium tuberculosis

First-of-its-kind study reveals a new culprit in the formation of brain hemorrhages

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News